These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 17083363)
1. Diverse phenotype of Brooke-Spiegler syndrome associated with a nonsense mutation in the CYLD tumor suppressor gene. Zhang G; Huang Y; Yan K; Li W; Fan X; Liang Y; Sun L; Li H; Zhang S; Gao M; Du W; Yang S; Liu J; Zhang X Exp Dermatol; 2006 Dec; 15(12):966-70. PubMed ID: 17083363 [TBL] [Abstract][Full Text] [Related]
2. Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene. Oiso N; Mizuno N; Fukai K; Nakagawa K; Ishii M Br J Dermatol; 2004 Nov; 151(5):1084-6. PubMed ID: 15541090 [TBL] [Abstract][Full Text] [Related]
5. Novel and recurrent germline and somatic mutations in a cohort of 67 patients from 48 families with Brooke-Spiegler syndrome including the phenotypic variant of multiple familial trichoepitheliomas and correlation with the histopathologic findings in 379 biopsy specimens. Grossmann P; Vanecek T; Steiner P; Kacerovska D; Spagnolo DV; Cribier B; Rose C; Vazmitel M; Carlson JA; Emberger M; Martinek P; Pearce RL; Pearn J; Michal M; Kazakov DV Am J Dermatopathol; 2013 Feb; 35(1):34-44. PubMed ID: 23249834 [TBL] [Abstract][Full Text] [Related]
6. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation. Bowen S; Gill M; Lee DA; Fisher G; Geronemus RG; Vazquez ME; Celebi JT J Invest Dermatol; 2005 May; 124(5):919-20. PubMed ID: 15854031 [TBL] [Abstract][Full Text] [Related]
7. A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome. Hu G; Onder M; Gill M; Aksakal B; Oztas M; Gürer MA; Celebi JT J Invest Dermatol; 2003 Oct; 121(4):732-4. PubMed ID: 14632188 [TBL] [Abstract][Full Text] [Related]
8. Brooke-Spiegler syndrome: report of a case of multiple cylindromas and trichoepitheliomas. Doherty SD; Barrett TL; Joseph AK Dermatol Online J; 2008 Jul; 14(7):8. PubMed ID: 18718192 [TBL] [Abstract][Full Text] [Related]
9. New mutation in the CYLD gene within a family with Brooke-Spiegler syndrome. Scholz IM; Nümann A; Froster UG; Helmbold P; Enk AH; Näher H J Dtsch Dermatol Ges; 2010 Feb; 8(2):99-101. PubMed ID: 20151946 [TBL] [Abstract][Full Text] [Related]
10. Brooke-Spiegler syndrome: report of a case with a novel mutation in the CYLD gene and different types of somatic mutations in benign and malignant tumors. Kazakov DV; Schaller J; Vanecek T; Kacerovska D; Michal M J Cutan Pathol; 2010 Aug; 37(8):886-90. PubMed ID: 20132422 [TBL] [Abstract][Full Text] [Related]
11. Familial cylindromatosis and brooke-spiegler syndrome: a review of current therapeutic approaches and the surgical challenges posed by two affected families. Rajan N; Trainer AH; Burn J; Langtry JA Dermatol Surg; 2009 May; 35(5):845-52. PubMed ID: 19397670 [No Abstract] [Full Text] [Related]
12. A case of Brooke-Spiegler syndrome with a novel germline deep intronic mutation in the CYLD gene leading to intronic exonization, diverse somatic mutations, and unusual histology. Kazakov DV; Thoma-Uszynski S; Vanecek T; Kacerovska D; Grossmann P; Michal M Am J Dermatopathol; 2009 Oct; 31(7):664-73. PubMed ID: 19668078 [TBL] [Abstract][Full Text] [Related]
14. Morphologic diversity of malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma based on the study of 24 cases, sporadic or occurring in the setting of Brooke-Spiegler syndrome. Kazakov DV; Zelger B; Rütten A; Vazmitel M; Spagnolo DV; Kacerovska D; Vanecek T; Grossmann P; Sima R; Grayson W; Calonje E; Koren J; Mukensnabl P; Danis D; Michal M Am J Surg Pathol; 2009 May; 33(5):705-19. PubMed ID: 19194280 [TBL] [Abstract][Full Text] [Related]
15. The CYLD p.R758X worldwide recurrent nonsense mutation detected in patients with multiple familial trichoepithelioma type 1, Brooke-Spiegler syndrome and familial cylindromatosis represents a mutational hotspot in the gene. Farkas K; Deák BK; Sánchez LC; Martínez AM; Corell JJ; Botella AM; Benito GM; López RR; Vanecek T; Kazakov DV; Kromosoeto JN; van den Ouweland AM; Varga J; Széll M; Nagy N BMC Genet; 2016 Feb; 17():36. PubMed ID: 26861065 [TBL] [Abstract][Full Text] [Related]
17. Identification of a recurrent mutation in the CYLD gene in Brooke-Spiegler syndrome. Scheinfeld N; Hu G; Gill M; Austin C; Celebi JT Clin Exp Dermatol; 2003 Sep; 28(5):539-41. PubMed ID: 12950348 [TBL] [Abstract][Full Text] [Related]
18. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity. Almeida S; Maillard C; Itin P; Hohl D; Huber M J Invest Dermatol; 2008 Mar; 128(3):587-93. PubMed ID: 17851586 [TBL] [Abstract][Full Text] [Related]
19. A clinicopathologic and molecular biologic study of patients presenting with few adnexal tumors (two to four) from the morphological spectrum of Brooke-Spiegler syndrome. Kacerovska D; Vanecek T; Spagnolo DV; Bisceglia M; Zelger B; Michal M; Kazakov DV Am J Dermatopathol; 2013 Feb; 35(1):19-24. PubMed ID: 22588548 [TBL] [Abstract][Full Text] [Related]
20. Phenotype diversity in familial cylindromatosis: a frameshift mutation in the tumor suppressor gene CYLD underlies different tumors of skin appendages. Poblete Gutiérrez P; Eggermann T; Höller D; Jugert FK; Beermann T; Grussendorf-Conen EI; Zerres K; Merk HF; Frank J J Invest Dermatol; 2002 Aug; 119(2):527-31. PubMed ID: 12190880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]